AJP - Heart and Circulatory Physiology, Vol 267, Issue 1 57-H65, Copyright © 1994 by American Physiological Society

ARTICLES

Cardiac contractile function following repetitive brief ischemia: effects of nucleoside transport inhibition

K. A. Kirkeboen, A. Ilebekk, T. Tonnessen, E. Leistad, P. A. Naess, G. Christensen and G. Aksnes
University of Oslo, Institute for Experimental Medical Research, Ulleval Hospital, Norway.

The effects of nucleoside transport inhibition on cardiac contractile function were examined in anesthetized pigs subjected to five 6-min left anterior descending coronary artery (LAD) occlusions, separated by 20-min reperfusion, and followed by 150-min reperfusion. In group 1 (n = 8), saline was infused. In group 2 (n = 9), endogenous myocardial accumulation of adenosine was increased by intracoronary infusion of the specific nucleoside transport inhibitor R-75 231. Left ventricular segment lengths were recorded by ultrasonic crystals in the inner one-third of the myocardium. Percent systolic segment length shortening (SS) (normalized to percent of preischemic value) was significantly better maintained in the R-75 231 group compared with the saline group after each occlusion. SS in the saline group reached a nadir of 30% (22-40) at 30-min reperfusion after the last occlusion compared with 66% (54-73) in the R-75 231 group. In the R-75 231 group, but not in the saline group, maximal postischemic decline in SS and decline at 20-min reperfusion were significantly reduced following the last occlusion. We conclude that R-75 231, which inhibits nucleoside transport, attenuates contractile dysfunction following repetitive brief ischemia and results in a preconditioning-like effect against stunning in the pig. On the basis of the well-documented biochemical effects of R-75 231, increased accumulation of endogenous adenosine most likely explains these findings.

This article has been cited by other articles:

				M. P. S. Randhawa Jr., R. D. Lasley, and R. M. Mentzer Jr. Salutary effects of exogenous adenosine administration on in vivo myocardial stunning J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 63 - 74. [Abstract] [Full Text]